What Really Counts as a Control Group in Research?

Why 'No Treatment' is unethical*

I can't recall the last time I wasn't asked this question after a research review committee meeting: "Should a control group always be a no-treatment group?"

I frequently hear ethical committee members stating, "Both groups in your study are experimental; you don't have a control group, meaning you don't have a group with NO treatment." I often find myself explaining that this isn't the correct way to understand control groups, but my explanations are rarely successful.

Today, once again, one of my students posed the same question: "Should a control group always be a no-treatment group?" I've decided to compile my response here, hoping to clarify the confusion surrounding the concept of control groups.

In scientific research, a control group is a fundamental component of experimental design. It serves as a baseline or standard for comparison against the experimental group(s) to determine the effect of a variable or intervention. The primary purpose of a control group is to isolate the effects of the independent variable, allowing researchers to attribute any observed changes in the dependent variable specifically to the intervention or treatment being studied.

Classification of Control Groups

Control groups in research (Medicine) are broadly classified into active control groups and inactive control groups.

1.      Active Control Groups

Active control groups consist of participants who receive a treatment or intervention that has known effects. This type of control group is commonly used in studies where the aim is to compare the new experimental treatment against an existing standard treatment. The purpose is to determine whether the new intervention is more, less, or equally effective as the current standard.

Ethical considerations often necessitate the use of active control groups, particularly when withholding treatment could be harmful or unethical.

2.      Inactive Control Groups

Inactive control groups consist of participants who do not receive an active treatment. This group may receive a placebo/sham, no treatment, or an intervention with no known therapeutic effect. Inactive control groups are important for establishing a baseline for comparison, as they help account for placebo effects and natural changes in the condition being studied. However, Inactive control group are only used when it is ethically acceptable to withhold treatment.*

For example, when no established, effective treatment exists for a particular condition, withholding treatment does not deprive participants of a known beneficial therapy. In such cases, a no-treatment control group may serve as a baseline to compare the effects of new interventions.

Example scenario: In a study examining the effects of a new exercise intervention on a rare neuromuscular disorder for which there is no standard treatment, a no-treatment control group may be used to assess the natural progression of the disorder.

Very often, people claim effectiveness of a new intervention based on a placebo-controlled trail. A new intervention did better than placebo?! It makes no sense, does it?

Here is an example:

A clinical trial was conducted to test the hypothesis that dry needling is more effective than sham dry needling in relieving myofascial pain of the temporomandibular muscles. The authors concluded “ Dry needling appears to be an effective treatment method in relieving the pain and tenderness of myofascial trigger points”. They forgot to add the word placebo in their conclusion. How convenient!

Unfortunately these kind of misinterpretation and misguiding conclusions for very common.

For all practical purposes, a clinician would like to know whether a new intervention is better than a conventional or a standard care that she/he is currently delivering. If not, why bother?

You may ask: then why placebo controlled studies are conducted? Well, its a topic for another discussion. The bottom line is, for clinicians it has no value.

In summary, the choice between an active and inactive control group depends on the research question, ethical considerations, and the nature of the condition or intervention being studied. Both types of control groups provide valuable information, but they address different aspects of the intervention's effectiveness and safety.

Below are some common types of control groups

1. Placebo Control Group

In clinical trials, participants in the placebo control group receive an inert substance or treatment that has no therapeutic effect. This group is used to assess the efficacy of the experimental treatment and to control for the placebo effect, where participants experience changes due to their expectations rather than the treatment itself.

2. No-Treatment Control Group

In this setup, the control group receives no intervention or treatment. This type of control group helps determine the natural progression of the condition or phenomenon being studied, providing a baseline for comparison with the experimental group. Remember the specific conditions for using no treatment group (discussed above)

3. Standard Treatment Control Group

In studies where a new treatment is being tested, the control group may receive the standard or conventional treatment. This allows for a direct comparison between the new treatment and the current standard of care.

4. Active Control Group

Similar to the standard treatment control group, the active control group receives an active treatment that is different from the experimental intervention. This is often used in comparative effectiveness research to determine which of two active treatments is more effective.

5. Waitlist Control Group

In this design, the control group is placed on a waitlist to receive the intervention after the study concludes. This type of control is often used in psychological and behavioral studies including exercise based interventions, where withholding treatment indefinitely may be unethical and a waitlisting constitute as a standard care.

6. Historical Control Group

In situations where it is not feasible to have a contemporaneous control group, researchers may use data from previous studies or records as a control. This type of control group is less trustworthy due to potential differences in study conditions, patient populations, and other variables.

7. Matched Control Group

Participants in the control group are matched with participants in the experimental group based on specific characteristics such as age, gender, or disease severity. This matching helps to reduce confounding variables that might influence the study's outcome. A common strategy used in Case-control study designs.

Let's revisit the statement mentioned earlier: "Only a no-treatment group can be a true control group."

This claim reflects a limited understanding of experimental design. While a no-treatment group is one form of a control group, it is not the only valid option. Further, it is imperative to understand that except in rare situations, using a no-treatment control group is unethical.

As discussed, the appropriateness of a control group depends on the study's objectives, the ethical background, and the nature of the intervention. Dismissing other types of control groups as invalid oversimplifies the complexity of research design.

The key criterion is not whether the control group receives no treatment but whether it provides a meaningful comparison that helps isolate the effect of the experimental intervention.